Health-Related Quality of Life Among Rural Chinese Patients With Upper Gastrointestinal Diseases at Different Pathological Stages: A Cross-Sectional Study

Tingting Qin, Yuchen Shao, Nan Zhang, Jialin Wang, Nengliang Yao, Deli Zhao, Weidong Liu, Roger T. Anderson, Xiaojie SunResearch Square 2020 · DOI

Abstract

Objective: To compare health-related quality of life (HR-QoL) among rural Chinese patients with upper gastrointestinal (GI) diseases across different pathological stages and identify influencing factors.
Methods: A cross-sectional survey of 406 patients in Shandong province used EORTC QLQ-C30, QLQ-OES18, and QLQ-STO22 questionnaires. Analysis included MANOVA, Kruskal–Wallis tests, and multivariate regression.
Results: Significant HR-QoL declines were observed in advanced stages compared to precancerous and early stages. Key factors included residence, age, education, and pathological stage.
Conclusions: Advanced upper GI cancer care must prioritize symptom management and tailored support based on patient demographics.

Introduction

Upper gastrointestinal cancers, particularly esophageal and gastric, remain leading causes of mortality in China. While clinical outcomes like survival rates have improved, the subjective experience of the patient—Health-Related Quality of Life (HR-QoL)—is often overlooked. This study focuses on rural populations, who face unique socioeconomic hurdles and limited healthcare access, to understand how well-being shifts across the pathological spectrum of GI disease.

Methods and Study Population

The researchers conducted a cross-sectional survey between July and September 2018 in Feicheng and Linqu counties, Shandong Province. These areas are known for high GI disease prevalence. A total of 406 patients were recruited and categorized into precancerous, early-stage, and advanced-stage groups.

Demographic and clinical characteristics of the 406 study participants.

HR-QoL was assessed using validated European Organization for Research and Treatment of Cancer (EORTC) instruments: the core QLQ-C30 for general symptoms, and the site-specific QLQ-OES18 (esophageal) and QLQ-STO22 (gastric) modules.

Key Results

The study identified a significant "quality of life cliff" as patients transitioned to advanced stages. While there were minimal differences in HR-QoL between precancerous and early-stage groups, advanced-stage patients experienced sharp declines in physical, social, and emotional functioning.

Mean scores of EORTC QLQ-C30 showing the decline in quality of life and functioning at advanced pathological stages.

The Impact of Disease Stage

Global QoL scores dropped significantly in the advanced group (56.25 for esophageal; 61.67 for gastric) compared to earlier stages (~70-79). Symptom severity, including fatigue, pain, and appetite loss, increased dramatically in advanced stages (p < 0.0001). For esophageal patients, reflux and swallowing difficulties were particularly debilitating, while gastric patients faced increasing anxiety as the disease progressed.

Socioeconomic Influences

Multivariate regression revealed that education level and residence area were critical predictors of HR-QoL. Higher education correlated with better outcomes, likely due to improved health literacy and coping mechanisms. Furthermore, the high scores for "financial difficulties" across all groups—particularly for esophageal patients—highlight the significant economic burden of long-term GI disease care in rural China.

Conclusion

The findings underscore the necessity of integrating palliative care and symptom management into standard oncological workflows, particularly for advanced-stage patients. Tailored care models that address the specific psychological and financial needs of rural populations—accounting for age and education—are essential to improving the overall well-being of patients with upper GI diseases.

Summary updated

Abstract

<title>Abstract</title> <bold>Objective:</bold> The aim of this study was to compare the health-related quality of life (HR-QoL) among rural Chinese patients with upper gastrointestinal (GI) diseases at different pathological stages and to determine the factors influencing HR-QoL in this population.<bold>Methods:</bold> A cross-sectional survey was conducted in two counties in Shandong province in China from July to September 2018. Demographic and clinical characteristics were collected, and HR-QoL of patients was assessed using a set of questionnaires, including the EORTC QLQ-C30 (V3.0), the QLQ-OES18 and the QLQ-STO22. Multivariate analysis of variance (MANOVA) and Kruskal–Wallis test were used to compare the HR-QoL of patients of different pathological stage subgroups, and multivariate regression analyses were used to determine influencing factors.<bold>Results: </bold>A total of 406 patients were included in this study. The mean scores for patients with upper GI diseases were 74.88 (<italic>SD</italic>=19.15), 8.04 (<italic>SD</italic>=16.17) and 8.64 (<italic>SD</italic>=16.96) for the global QoL scale of EORTC QLQ-C30, QLQ-OES18 and QLQ-STO22, respectively. There was no significant difference in most of the scales between the precancerous and early stage groups, but a significant difference in HR-QoL between the precancerous and advanced groups as well as between early and advanced groups. Residence area, age, education level and pathological stage were the significant factors influencing HR-QoL scores, controlling for other variables.<bold>Conclusions: </bold>The overall HR-QoL of patients with advanced upper GI cancer needs to be managed as a component of cancer care. Measures should be taken to routinely identify patient symptoms so that follow-up care can alleviate patient symptom burden. Tailored treatment and care for patients with upper GI diseases of different age, educational level and pathological stage may be needed to help improve HR-QoL.
BibTeX
@inproceedings{qin2020health,
  author = {Tingting Qin and Yuchen Shao and Nan Zhang and Jialin Wang and Nengliang Yao and Deli Zhao and Weidong Liu and Roger T. Anderson and Xiaojie Sun},
  title = {{Health-Related Quality of Life Among Rural Chinese Patients With Upper Gastrointestinal Diseases at Different Pathological Stages: A Cross-Sectional Study}},
  booktitle = {Research Square},
  year = {2020},
  doi = {10.21203/rs.3.rs-31481/v1},
}
Figure